Company Filing History:
Years Active: 1977
Title: The Innovations of Robert H. Springer
Introduction
Robert H. Springer is a notable inventor based in Santa Ana, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for various enzymes. With a total of two patents to his name, his work has implications for medical advancements.
Latest Patents
Springer's latest patents include the development of 2-Substituted-s-triazolo[1,5a]pyrimidines. These compounds are disclosed as useful inhibitors of phosphodiesterase enzymes or intermediates in the production process. The structure of these compounds is defined by specific variables, including X, R, R1, R2, and R3. Additionally, he has worked on xanthine oxidase inhibitors, which are effective in inhibiting the enzyme xanthine oxidase. The compounds in this patent feature an aromatic or substituted aromatic nucleus, with R being an alkali metal or ammonium.
Career Highlights
Robert H. Springer is associated with Icn Pharmaceuticals, Inc., where he has been able to apply his innovative ideas in a practical setting. His work has contributed to the advancement of pharmaceutical research and development.
Collaborations
Some of his notable coworkers include Darrell E. O'Brien and Lionel N. Simon. Their collaborative efforts have likely enhanced the research and development processes within their projects.
Conclusion
Robert H. Springer is a distinguished inventor whose work in enzyme inhibitors has the potential to impact the pharmaceutical industry significantly. His contributions continue to pave the way for future innovations in medicine.